Help us reach our goal
Thank you for supporting this initiative, your fundraising efforts will make a real difference.
Thank you for your interested in supporting our organisation and medical research into DIPG. Your fundraising efforts will make a real difference.
To make fundraising easier, you can make one-off donation direct to RUN DIPG through this page.
If you are interested in participating in a fundraising event, we’ve created a platform to give you the ability to create your own online fundraising page. In just minutes you can build and customise your page, then start sharing the link with your friends, family and colleagues and asking them to make a donation. Every donation is then recorded on your fundraising page along with a message of support from your donors. So what are you waiting for? Create your own online fundraising page today!
Donate Now
RUN DIPG Donation
LATEST ARTICLES
Together we make all the difference
US FDA Grants Rare Pediatric Disease Designation for treatment of DIPG
Dr Matt Dun is a University of Newcastle and HMRI biologist leading leukaemia research projects, but has also become driven to use his knowledge and skills to dig deeper into DIPG
Newcastle Herald: Dun Lab breakthrough
Dr Matt Dun is a University of Newcastle and HMRI biologist leading leukaemia research projects, but has also become driven to use his knowledge and skills to dig deeper into DIPG
RUNDIPG: PhD Scholarship at HMRI
Run DIPG is thrilled to announce that we are funding a PhD scholarship
2019 NSW Premier’s Awards
2019 NSW Premier's Awards for Outstanding Cancer Research – Outstanding Cancer Research Fellow
SMH: Matt Dun’s mission to conquer cancer
Dr Matt Dun is a University of Newcastle and HMRI biologist leading leukaemia research projects, but has also become driven to use his knowledge and skills to dig deeper into DIPG
CHANGE A LIFE TODAY
We are a charitable organisation dedicated to improving treatment outcomes for children diagnosed with diffuse intrinsic pontine glioma (DIPG). DIPG is the deadliest form of childhood cancer with an average survival rate of just nine months following diagnosis.